Chris Collins, a Republican for New York’s 27th Congressional District, was indicted on insider trading charges involving an Australian biotechnology company for which he serves as a board member, federal prosecutors announced on Aug. 8.
The indictment also named two others: the congressman’s son, Cameron Collins, and the father of his fiance, Stephen Zarsky. Prosecutors accused the congressman of passing sensitive drug-test results from the company, Innate Immunotherapeutics, to his son in June 2017, so that he could trade on Innate’s stock.